Titan Medical to Release Second Quarter 2021 Financial Results on August 11, 2021 | Company


TORONTO – (BUSINESS WIRE) – August 3, 2021–

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for single-access robotic surgery, today announced that the company plans to release its results financials for the second quarter of 2021 before marketing. opening Wednesday, August 11, 2021. In addition, management will host an audio webcast for investors at 8:30 a.m. ET to discuss financial results and company highlights. Speakers will include David McNally, President and Chief Executive Officer, and Stephen Lemieux, Chief Financial Officer.

A link to the live audio webcast will be available in the “Investor Relations” section of the Company’s website, www.titanmedicalinc.com. A replay of the webcast will be archived and available on the Company’s website shortly after the end of the live audio webcast.

About Titan Medical

Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company headquartered in Toronto, Ontario and with R&D facilities in Chapel Hill, North Carolina, focuses on the improving robot-assisted surgery using innovative technology through a single point of access. The Enos â„¢ Single Access Robotic Surgical System is developed with an ergonomic approach to provide a surgical experience that mimics the real movements that surgeons demand and includes multi-articulated instruments designed to allow surgeons a greater range of motion in a space. confined, with the dexterity and ability to exert the forces necessary to perform routine surgical tasks. With the Enos system, Titan initially intends to pursue gynecological surgical indications.

Certain of Titan’s robot-assisted surgical technologies and related intellectual property have been licensed to Medtronic plc, while retaining worldwide commercialization rights to technologies for use with the Enos system.

Enos â„¢ is a trademark of Titan Medical Inc.

For more information, please visit www.titanmedicalinc.com.

Forward-looking statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws in Canada and the United States, which reflect management’s current expectations regarding the future growth of the Company, results of operations, performance and business prospects and opportunities. Whenever possible, words such as “could”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend” of ”,“ estimate ”,“ the potential for ”and similar expressions have been used to identify such forward-looking statements, including, without limitation, references to: the Company’s emphasis on design and developing surgical technologies for single access robotic surgery, the Enos system is developed with dual 3D and 2D high definition vision systems, multi-articulated instruments and an ergonomic workstation for the surgeon, and that Titan has the ‘intention to continue with gynecological surgical indications as a first step. These statements reflect the current beliefs of management and are based on information currently available to management. Forward-looking statements involve important risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements of the Company to differ materially from future results, performance or achievements that could be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the Company’s Annual Information Form and Form 40-F for the fiscal year ended December 31, 2020 (which can be viewed at www.sedar.com and to www.sec.gov ). If one or more of these risks or uncertainties materialize, or if the assumptions underlying forward-looking statements prove to be incorrect, actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements contained in this Press release. These factors should be carefully considered and potential investors should not place undue reliance on forward-looking statements. Although the forward-looking statements contained in the press release are based on what management currently considers to be reasonable assumptions, the Company cannot assure potential investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, the Company expressly disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210803005199/en/

CONTACT: Kristen Galfetti

Vice President Investor Relations

+ 1-781-869-2553

[email protected]



SOURCE: Titan Medical Inc.

Copyright Business Wire 2021.

PUB: 08/03/21 07:30 / DISC: 08/03/2021 07:32


Copyright Business Wire 2021.


About Author

Leave A Reply